Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Zoetis Inc. announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.
Zoetis : Acquires Veterinary Pathology Group to Strengthen Veterinary Diagnostics in UK and Ireland
Zoetis Inc. today announced the acquisition of Veterinary Pathology Group (VPG), a leading veterinary diagnostic laboratory group with multiple locations across the UK and Ireland. The acquisition further expands Zoetis' comprehensive diagnostics portfolio and reinforces its commitment to advancing animal health through innovative, high-quality diagnostic solutions.
Money, Mistrust, and Machines: What’s Shaping the Future of Vet Med
In the latest episode of Vet Candy Watch, Career Coach Vet Dr. Ashley Hopkins takes a closer look at the biggest conversations shaping the veterinary profession today. From economic realities to public perception and global innovation, this episode explores the issues that every veterinary professional should be paying attention to.
Instinct Science and Cornell University Hospital for Animals Modernize Veterinary Care
Instinct Science, a leading provider of clinical-grade software for veterinary hospitals, today announced that the Cornell University Hospital for Animals (CUHA) has officially gone live with Instinct Treatment Plan, a next-generation digital platform that brings structure, clarity, and automation to patient care workflows.
One Van, One Vision: How Dr. Tom Vega Turned His Dream Into Chicago's Most Innovative Mobile Practice
r. Tom Vega, a Chicago-based veterinarian, founded Concierge Companions VetMed with a clear mission: to reimagine the client and patient experience through personalized, elevated, and compassionate care. After years as a trusted relief veterinarian across the Chicagoland area, Dr. Vega built his practice to deliver gold-standard medicine on his clients' schedules, blending advanced diagnostics with a concierge-level experience.
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
With new label, Dectomax®-CA1 Injectable is the first and only parasite control product with conditional approval to help control economically devastating pest Cochliomyia hominivorax (New World screwworm)